Cover Image
市場調查報告書

胰臟癌:全球臨床實驗趨勢

Pancreatic Cancer Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 228234
出版日期 內容資訊 英文 1492 Pages
訂單完成後即時交付
價格
Back to Top
胰臟癌:全球臨床實驗趨勢 Pancreatic Cancer Global Clinical Trials Review, H1, 2017
出版日期: 2017年03月15日 內容資訊: 英文 1492 Pages
簡介

本報告提供全球胰臟癌治療藥臨床實驗上之相關調查,提供您各地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各種贊助企業臨床實驗資料,臨床實驗主要的參與企業,有潛力的藥劑,最新臨床實驗相關新聞等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5國的臨床實驗數量
    • 中南美主要5國的臨床實驗數量

G7各國臨床實驗數量:癌症治療藥臨床實驗上胰臟癌的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:癌症治療藥臨床實驗上胰臟癌的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

胰臟癌治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Pancreatic Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Pancreatic Cancer Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Latest Clinical Trials News on Pancreatic Cancer 30
  • Feb 21, 2017: Bellicum Announces Initiation of Patient Dosing with Controllable CAR T-Cell Product Candidate 30
  • Feb 21, 2017: Spring Bank Pharmaceuticals to Present Results from In Vivo Studies of SB 11285, a Novel STING agonist for Immuno-Oncology, at Keystone Symposia 30
  • Feb 21, 2017: PharmaCyte Biotech Discusses Patient Enrollment and TD2s Role in Upcoming Clinical Trial 30
  • Feb 02, 2017: Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients 31
  • Jan 27, 2017: Redx outlines growing opportunity for Porcupine inhibitors 32
  • Jan 20, 2017: ARMO BioSciences Presents New Phase 1b Clinical Data for AM0010 in Advanced Pancreatic Cancer Patients at 2017 Gastrointestinal Cancers Symposium 32
  • Jan 20, 2017: Pamrevlumab Pancreatic Cancer Clinical Data Presented at ASCO 2017 Gastrointestinal Cancers Symposium 33
  • Jan 20, 2017: ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor CCX872 in Patients with Advanced Non-Resectable Pancreatic Cancer 33
  • Jan 17, 2017: BioLineRx Announces Initiation of Immuno-Oncology Phase 2 Study to Investigate Combination of BL-8040 and KEYTRUDA for Pancreatic Cancer 34
  • Jan 11, 2017: Celyad Announces Registration of the First Pancreatic Cancer Patient in its CAR-T NKR-2THINK Trial in Belgium 35
  • Jan 05, 2017: Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints 35
  • Dec 23, 2016: Anti-AXL Biologic Increases Tumor Sensitivity to Radiation and Check-Point Inhibitors 36
  • Dec 22, 2016: Propanc Commences GLP-Compliant 28-Day Repeat-Dose Toxicity Study 36
  • Dec 12, 2016: PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial 36
  • Clinical Trial Profile Snapshots 38

Appendix 1489

  • Abbreviations 1489
  • Definitions 1489
  • Research Methodology 1490
  • Secondary Research 1491
  • About GlobalData 1491
  • Contact Us 1491
  • Disclaimer 1492
  • Source 1492

List of Tables

List of Tables

  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
  • Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

List of Figures

  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
  • Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
  • GlobalData Methodology 1490
Back to Top